{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:09Z","timestamp":1793397909844,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian National Council on Drugs (ANCD)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.drugalcdep.2018.06.038","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T20:07:43Z","timestamp":1534968463000},"page":"309-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Pharmacotherapy for amphetamine dependence: A systematic review"],"prefix":"10.1016","volume":"191","author":[{"given":"Nicole K.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Harney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqui","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"Anderson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2015.01.036","article-title":"Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial","volume":"150","author":"Anderson","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0025","article-title":"Fluoxetine in methamphetamine dependence - a controlled trial: a preliminary analysis","author":"Batki","year":"1999","journal-title":"The 61st Annual Scientific Meeting of the College on Problems of Drug Dependence"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0030","first-page":"12","article-title":"Amlodipine treatment of methamphetamine dependence, a controlled outpatient trial: preliminary analysis","volume":"63","author":"Batki","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/dar.12048","article-title":"Pharmacotherapy of amphetamine-type stimulant dependence: an update","volume":"32","author":"Brensilver","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/syn.20097","article-title":"Safety and efficacy of \u03b3\u2010vinyl GABA (GVG) for the treatment of methamphetamine and\/or cocaine addiction","volume":"55","author":"Brodie","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0045","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/npp.2012.142","article-title":"The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T (1)H-MRS study","volume":"37","author":"Cai","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0050","series-title":"Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS Publication No SMA 15-4927, NSDUH Series H-50","author":"Center for Behavioral Health Statistics and Quality","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0376-8716(98)00052-0","article-title":"Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison","volume":"52","author":"Charnaud","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0060","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archgenpsychiatry.2011.124","article-title":"Mirtazapine to reduce methamphetamine use: a randomized controlled trial","volume":"68","author":"Colfax","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0065","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/add.12073","article-title":"Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial","volume":"108","author":"Coffin","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","article-title":"Major physical and psychological harms of methamphetamine use","volume":"27","author":"Darke","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0080","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2009.02872.x","article-title":"Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization","volume":"105","author":"Darke","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/QAD.0b013e328336e98b","article-title":"Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men","volume":"24","author":"Das","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2009.06.008","article-title":"Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables","volume":"105","author":"Dean","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/14740338.2011.585966","article-title":"Drug safety evaluation of amlodipine","volume":"10","author":"Derosa","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0100","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0105","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1360-0443.2011.03771.x","article-title":"Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial","volume":"107","author":"Elkashef","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0110","series-title":"European Drug Report 2017: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/clpt.2010.307","article-title":"A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction","volume":"89","author":"Galloway","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-2396(199910)34:1<11::AID-SYN2>3.0.CO;2-5","article-title":"Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine","volume":"34","author":"Gerasimov","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0125","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","article-title":"A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence","volume":"20","author":"Grant","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0135","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bmj.38636.593461.68","article-title":"Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources","volume":"331","author":"Greenhalgh","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0140","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-0009.2009.00578.x","article-title":"Tensions and paradoxes in electronic patient record research: a systematic literature review using the meta\u2010narrative method","volume":"87","author":"Greenhalgh","year":"2009","journal-title":"Milbank Q."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5694\/mja13.10149","article-title":"Trends in amphetamine-related harms in Victoria","volume":"199","author":"Heilbronn","year":"2013","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2006.03.019","article-title":"Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence","volume":"85","author":"Heinzerling","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2009.11.023","article-title":"Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence","volume":"109","author":"Heinzerling","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0160","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/add.12636","article-title":"Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use","volume":"109","author":"Heinzerling","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2009.05145.x","article-title":"Agonist\u2010like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies","volume":"1187","author":"Herin","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugalcdep.2014.07.031","article-title":"Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses","volume":"143","author":"Hermanstyne","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0175","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08039480510023052","article-title":"An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability","volume":"59","author":"Jayaram-Lindstrom","year":"2005","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0190","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145707007778","article-title":"A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence","volume":"11","author":"Johnson","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0200","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review","volume":"69","author":"Karila","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1521-0391.2013.00320.x","article-title":"A retrospective assessment of the use of naltrexone implants for the treatment of problematic amphetamine use","volume":"22","author":"Kelty","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-6-3","article-title":"Treatment utilization and barriers to treatment: results of a survey of dependent methamphetamine users","volume":"6","author":"Kenny","year":"2011","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.11.004","article-title":"Measures of outcome for stimulant trials: ACTTION recommendations and research agenda","volume":"158","author":"Kiluk","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2648.2012.06064.x","article-title":"What are the core elements of patient\u2010centred care? A narrative review and synthesis of the literature from health policy, medicine and nursing","volume":"69","author":"Kitson","year":"2013","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.11.006","article-title":"Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study","volume":"108","author":"Konstenius","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-9338(13)76230-8","article-title":"1128\u2013methylphenidate for ADHD in adults with substance dependence: a 24-week randomized placebo-controlled trial","volume":"28","author":"Konstenius","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0235","series-title":"Medication Treatment Options for Amphetamine-type Stimulant Users. ANCD Research Paper 29","author":"Lee","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09595230801919494","article-title":"A systematic review of cognitive and behavioral therapies for methamphetamine dependence","volume":"27","author":"Lee","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0245","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0250","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/add.12608","article-title":"Sustained\u2010release methylphenidate in a randomized trial of treatment of methamphetamine use disorder","volume":"109","author":"Ling","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1360-0443.2011.03619.x","article-title":"Double-bline placebo-controlled evaluation of the PROMETA\u2122 protocol for methamphetamine dependence","volume":"107","author":"Ling","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1360-0443.2009.02717.x","article-title":"Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence","volume":"105","author":"Longo","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0265","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.psychres.2018.02.017","article-title":"Profile of psychiatric symptoms in methamphetamine users in China: greater risk of psychiatric symptoms with a longer duration of use","volume":"1","author":"Ma","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0270","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0275","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1755-5949.2011.00263.x","article-title":"A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial","volume":"18","author":"McCann","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/00952990802342907","article-title":"Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study","volume":"35","author":"McEihiney","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/JCP.0b013e3181b591e0","article-title":"Open-label pilot study of modafinil for methamphetamine dependence","volume":"29","author":"McGaugh","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0290","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1360-0443.2012.03933.x","article-title":"Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)","volume":"107","author":"Mcketin","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0295","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2006.04.007","article-title":"The relationship between crystalline methamphetamine use and methamphetamine dependence","volume":"85","author":"McKetin","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0300","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","article-title":"The prevalence of psychotic symptoms among methamphetamine users","volume":"101","author":"McKetin","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0305","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/add.12474","article-title":"Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study","volume":"109","author":"McKetin","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0310","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2007.10399875","article-title":"An open-label pilot study of risperidone in the treatment of methamphetamine dependence","volume":"39","author":"Meredith","year":"2007","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ADM.0b013e31818e2185","article-title":"Open trial of injectable risperidone for methamphetamine dependence","volume":"3","author":"Meredith","year":"2009","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0320","first-page":"94","article-title":"Dexamphetamine substitution as a treatment of amphetamine dependence: a two-centre randomised controlled trial","volume":"12","author":"Merrill","year":"2005","journal-title":"Drugs (Abingdon Engl.)"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0325","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/add.12109","article-title":"Extended-release methylphenidate for treatment of amphetamine\/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial","volume":"108","author":"Miles","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0330","first-page":"435","article-title":"Methylphenidate substitution for methamphetamine addiction and implications for future randomized clinical trials: a unique case series","volume":"21","author":"Minarik","year":"2016","journal-title":"Int. J. Prev. Treat. Subst. Use Disord."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clpt.2003.09.004","article-title":"Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence","volume":"75","author":"Montoya","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0345","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/ADM.0000000000000218","article-title":"Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder","volume":"10","author":"Mooney","year":"2016","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0350","first-page":"28","article-title":"The efficacy of n-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study","volume":"18","author":"Mousavi","year":"2015","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0355","series-title":"NHMRC Additional Levels of Evidence and Grades for Recommendations for Developers of Guidelines","author":"National Health and Medical Research Council","year":"2009"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0360","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pbb.2011.04.015","article-title":"Glutamatergic medications for the treatment of drug and behavioral addictions","volume":"100","author":"Olive","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0365","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/ADM.0000000000000107","article-title":"Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study","volume":"9","author":"Pal","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0370","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","article-title":"Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings","volume":"129","author":"Panenka","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0375","first-page":"CD009695","article-title":"Efficacy of psychostimulant drugs for amphetamine abuse or dependence","author":"Perez-Mana","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0380","article-title":"Meta-narrative review","author":"Potts","year":"2012","journal-title":"Proceedings of the 5th Economic and Social Research Council Research Methods Festival"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40199-015-0092-y","article-title":"Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial","volume":"23","author":"Rezaei","year":"2015","journal-title":"Daru"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0390","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/fcp.12178","article-title":"Topiramate for the management of methamphetamine dependence: a pilot randomized, double\u2010blind, placebo\u2010controlled trial","volume":"30","author":"Rezaei","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0395","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0400","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10401230802177656","article-title":"Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions","volume":"20","author":"Rose","year":"2008","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0405","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/JCP.0000000000000408","article-title":"The effect of buprenorphine on methamphetamine cravings","volume":"35","author":"Salehi","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0410","series-title":"Application for Inclusion to the 19th Expert Committee on the Selection and Use of Essential Medicines: Risperidone","author":"Salwan","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0415","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: a critical review and meta-analysis","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0420","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/add.12740","article-title":"High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia","volume":"110","author":"Scott","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0425","series-title":"SIGN 50: A Guideline Developer\u2019s Handbook","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0430","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2001.96912898.x","article-title":"Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence","volume":"96","author":"Shearer","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0435","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine dependence","volume":"104","author":"Shearer","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0440","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2006.03.005","article-title":"Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence","volume":"85","author":"Shoptaw","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0445","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0450","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsps.2013.04.003","article-title":"Methylphenidate vs. resperidone in treatment of methamphetamine dependence: a clinical trial","volume":"22","author":"Solhi","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0455","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.2174\/138161281940131209142843","article-title":"Agonist replacement for stimulant dependence: a review of clinical research","volume":"19","author":"Stoops","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0460","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/17512433.2014.909283","article-title":"Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research","volume":"7","author":"Stoops","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0465","article-title":"Varenicline for the treatment of methamphetamine dependence: a pilot study","author":"Swanson","year":"2011","journal-title":"Proceedings of the 73rd Annual Scientific Meeting of the College on Problems of Drug Dependence"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2008.09.008","article-title":"Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors","volume":"597","author":"Tadori","year":"2008","journal-title":"Euro. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0475","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.12846","article-title":"Influence of different drugs on HIV risk in people who inject: systematic review and meta\u2010analysis","volume":"110","author":"Tavitian\u2010Exley","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0480","series-title":"EndNote","author":"Thomson Reuters","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0485","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/ajp.2007.164.1.160","article-title":"A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence","volume":"164","author":"Tiihonen","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0490","series-title":"Systematic Reviews","author":"Torgerson","year":"2003"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0495","series-title":"World Drug Report 2016","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0500","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881109349837","article-title":"A Controlled Trial of Flumazenil and Gabapentin for Initial Treatment of Methylamphetamine Dependence","volume":"25","author":"Urschel","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0505","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4065\/82.10.1170","article-title":"Open-label study of a proprietary treatment programtargetting type Agamma-aminobutyic acidreceptor dysregulation in methamphetamine dependence","volume":"82","author":"Urschel","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0510","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1360-0443.2000.9522299.x","article-title":"Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation","volume":"95","author":"White","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0515","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/14659890600594112","article-title":"Dexamphetamine substitute-prescribing in pregnancy: a 10-year retrospective audit","volume":"11","author":"White","year":"2006","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0520","series-title":"What is a Realist Review and What Can it Do for Me? An Introduction to Realist Synthesis","author":"Wong","year":"2009"},{"key":"10.1016\/j.drugalcdep.2018.06.038_bib0525","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.drugalcdep.2011.04.015","article-title":"Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine","volume":"118","author":"Zorick","year":"2011","journal-title":"Drug Alcohol Depend."}],"updated-by":[{"DOI":"10.1016\/j.drugalcdep.2018.09.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618304599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618304599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T13:41:17Z","timestamp":1751809277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618304599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":105,"alternative-id":["S0376871618304599"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.038","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy for amphetamine dependence: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}